Autistic Disorder Clinical Trial
Official title:
A Randomized Controlled Trial of D-Cycloserine in Autism
This study will determine the effectiveness of D-cycloserine in reducing symptoms of autism in autistic children.
This project proposes to study the efficacy and safety of D-cycloserine in children with
autism. The central hypothesis of this project is that D-cycloserine will be efficacious in
reducing certain symptoms of autism including some aspects of social impairment.
Autism is a severe neuropsychiatric disorder with a prevalence of at least 0.1 %. Despite
investigations into the pharmacologic treatment of autism, no drugs have been shown to
consistently improve the core symptoms of the disorder, namely social and communication
impairment. Pilot data has suggested that D-cycloserine, a drug that affects the
N-methyl-D-aspartate (NMDA) subtype of glutamate receptor, has efficacy for the symptom of
social withdrawal in autism. In this study, children with autism will be randomly assigned
to treatment with either D-cycloserine or placebo for 8 weeks. Both the subjects and
investigators will be blind to treatment assignment. Subjects will be rated on a variety of
clinical measures to examine the effects of D-cycloserine on social withdrawal and other
symptoms of autism. Safety data including side-effects, vital signs, blood tests, and
electrocardiograms will be performed at the beginning and end of the study. This study will
provide important information about the effects of D-cycloserine for treating core and
associated symptoms of autism. It will also greatly expand the knowledge about glutamatergic
agents in autism and provide crucial information regarding the pathophysiology and future
design of drug studies in autism.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03222375 -
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
|
N/A | |
| Completed |
NCT02568631 -
Improving Social Cognition for Adults With ASD by the Serious Game JeStiMulE Versus Controls
|
N/A | |
| Completed |
NCT02708290 -
Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD
|
||
| Completed |
NCT02369445 -
Investigation of Teacher-Mediated Toilet Training Using a Manualized Moisture Alarm Intervention
|
N/A | |
| Completed |
NCT01592747 -
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
|
Phase 2 | |
| Completed |
NCT01617460 -
A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder
|
Phase 3 | |
| Completed |
NCT01400269 -
An Evaluation of a Developmentally-Based Parent Training Program for Children With Autism
|
N/A | |
| Active, not recruiting |
NCT02442115 -
Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
|
||
| Completed |
NCT00926471 -
Social Skills and Anxiety Reduction Treatment for Children and Adolescents With Autism Spectrum Disorders
|
Phase 1 | |
| Completed |
NCT00365859 -
Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)
|
Phase 3 | |
| Completed |
NCT00692315 -
Treating Oxidative Stress in Children With Autism
|
N/A | |
| Completed |
NCT00198107 -
Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism
|
Phase 3 | |
| Completed |
NCT00095420 -
Relationship Training for Children With Autism and Their Peers
|
N/A | |
| Completed |
NCT00027404 -
Study of Fluoxetine in Adults With Autistic Disorder
|
N/A | |
| Recruiting |
NCT05910502 -
Project AFECT (Autism Family Empowerment Coaching and Training Program)
|
N/A | |
| Completed |
NCT04820998 -
Living in a Precarious Situation With an Autistic Child: What Are the Issues at Stake for Support in Care
|
||
| Withdrawn |
NCT05413187 -
A Trial to Assess the Efficacy and Safety of Medical Grade Cannabis in Children Diagnosed With Autism Spectrum Disorder
|
Phase 2 | |
| Recruiting |
NCT02275455 -
Design Of WELL Being Monitoring Systems, Application in Autism
|
N/A | |
| Completed |
NCT02766101 -
Manville Moves: an Exercise Intervention for Behavioral Regulation Among Children With Behavioral Health Challenges
|
N/A | |
| Completed |
NCT01977248 -
Sensorimotor Affect Relationship-based Therapy (SMART) for Children With Autism Spectrum Disorders Ages 2-12
|
N/A |